Systemic Lupus Erythematosus in Gullah Health
Medical University of South Carolina · with National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NCT00756769
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 2+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 750
- US sites recruiting
- 1
- Study start
- April 2003
- Record last updated
- July 28, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies, multiple organ involvement, and diverse clinical symptoms and immunologic manifestations. African Americans are at a disproportionately higher risk of developing SLE, develop SLE at an earlier age, and have increased morbidity and mortality compared with European Americans. Our central study hypothesis is that there are specific genetic factors that interact with environmental exposures leading to the development of SLE. The African American Gullah population from the Sea Islands of South Carolina and Georgia are unique in their genetic homogeneity with minimal non-African genetic admixture, making them an ideal cohort to address questions of environmental and genetic influence on the development and progression of SLE.
Conditions: Systemic Lupus Erythematosus
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 2 years and above;
- Self-identified as African-American "Gullah" from the Sea Island region of South Carolina;
- Have had at least 4 of the 11 diagnostic criteria for SLE as designated by the American College of Rheumatology (ACR), be a relative of a known SLE patient, or be an unrelated healthy Gullah control;
- Ability to speak and understand English;
- Ability and willingness to give informed consent
Exclusion Criteria
- Race defined by participant as other than Black or African-American;
- Being a prisoner, mentally ill patient, or institutionalized individual;
- Unwilling or unable to give informed consent
Recruiting US locations
Medical University of South Carolina
Charleston, SC 29425
Study contacts (from the official record)
- Diane L. Kamen, MD, MSCR · 843-792-4825 · kamend@musc.edu
Similar studies in South Carolina
All healthy volunteers studies in South Carolina →- RecruitingHealthy volunteers
Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments
Medical University of South Carolina
- Location
- Charleston, SC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Greenville, SC + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- North Charleston, SC + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- North Charleston, SC + 5 other US sites
- Eligibility basics
- Ages 18–65